K2Nytt er instituttavisen til Klinisk Institutt 2. Den ble started opp i januar 2013 etter den store omorganiseringen ved Det Medisinsk-Odontologiske Fakultet, og tok da over for IFI-info.
K2nytt lages av stipendiater og ansatte i administrasjonen, og kommer ut en gang i uken. Har du spørsmål eller kommentarer send dem gjerne på mail til redaktøren, eller legg dem inn i kommentarfeltene.
Nåværende medlemmer av redaksjonen:
Hege F. Berg – Redaktør
Irene Lavik Hjelmaas – Layout/back-up
Tonje Lomheim – Layout/back-up
Dear Sir/Ms
I am writing to you on behalf of the European Society for Translational Medicine regarding the 4th Annual Congress (EUSTM-2016). We would like to request for an event feature/listing or posting of EUSTM-2016 on your site. To have a better understanding, here are the event details:
—————————————————————————————————————
Event Organizers:
European Society for Translational Medicine (EUSTM)
Global Translational Medicine Consortium (GTMC)
Event Title:
4th International Congress on Translational Medicine
(4th Annual Congress of the European Society for Translational Medicine) (EUSTM-2016)
Prague, Czech Republic
October 17-20, 2016
Conference Website: http://www.eutranslationalmedicine.org/eustm-2016
Event Location
Orea Hotel Pyramida
Prague, Czech Republic
Event Description:
EUSTM-2016 will discuss and showcase latest developments in specific areas of cellular & molecular biology, big data mining & omics sciences, biomarkers & molecular imaging, drug discovery & development, Precision medicine & point of care diagnostics and disease modeling. The conference will unite scientists, clinicians, world leaders and experts from research institutions, industry, regulatory agencies, policy makers, and governments. EUSTM-2016 provides the key to future success in global healthcare by addressing current challenges and by highlight novel solutions.
Call for Abstracts:
EUSTM-2016 cordially welcomes high quality abstract submissions in the below mentioned topics and themes. The conference represents a unique platform to showcase your benchside (basic research) findings to an audience of multidisciplinary delegates from academia, clinics, industry, regulatory agencies and patient organizations.
Key Topics and Themes:
– Novel Findings & Updates in Cellular & Molecular Biology
– New Horizons in Big Data & Omics Sciences
– Latest Developments & Updates in Biomarkers & Molecular imaging
– New Horizons in Drug Discovery & Development
– New Developments & Updates in Precision Medicine & Point-of-Care Diagnostics
– Novel Findings & Updates in Disease Modeling
Submit your abstract here: http://eutranslationalmedicine.org/eustm-2016/submit-your-abstract/
Abstracts Publication
Abstracts will be published in the international peer reviewed journal, New Horizons in Translational Medicine (NHTM).
Sponsorship & Exhibition Opportunities
WHO WILL SHOWCASE THEIR SERVICES AND PRODUCTS:
The conference represents a unique opportunity to showcase and exhibit services & products for following types of companies:
• Pharma and biotech
• CROs
• IT applications & software companies
• Medtech & medical instruments companies
• Molecular biology & biochemistry laboratory reagents & services providers
• Genomics, proteomics & metabolomics services providers
• Discover & preclinical services providers
• Biomarkers services providers
• Data management companies
• Clinical services providers
• Consultancy firms
Download Prospectus: Sponsorship and Exhibition Opportunities (http://eutranslationalmedicine.org/eustm-2016/wp-content/uploads/2015/11/prospectus1.pdf)
For more information on sponsorship & exhibition opportunities, please visit:
http://eutranslationalmedicine.org/eustm-2016/sponsorship/
Contact Person:
Ms. Magdalena Pirker
Event Manager, EUSTM-2016
Vienna, Austria.
eustm-2016@eutranslationalmedicine.org
Phone: +43 1 8923 562
Fax: +43 1 8923 562
———————————————————————————————————————-
Thank you for your time and we hope to hear from you soon. Feel free to get in touch with me at eustm-2016@eutranslationalmedicine.org for any clarifications or questions.
Kind regards,